SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-14-000498
Filing Date
2014-10-07
Accepted
2014-10-07 16:26:20
Documents
1
Period of Report
2014-10-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 10-03-2014 form4.html 4  
1 FORM 4 FOR 10-03-2014 form4.xml 4 3107
  Complete submission text file 0001161697-14-000498.txt   4666
Mailing Address CATALYST PHARMACEUTICAL PARTNERS, INC. 355 ALHAMBRA CIRCLE, SUITE 1500 CORAL GABLES FL 33134
Business Address
MUTH DAVID D (Reporting) CIK: 0001111736 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 141145943

Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations